Related Experiment Video
Updated: Jun 14, 2025
09:03
Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
12.8K
Infectivity of a pathogenicity-attenuated Chlamydia muridarum mutant in the genital tract
Caiting Li1,2, Zhaoyang Liu2, Yaoqin Hua2
1Department of Dermatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Infection and Immunity
|May 23, 2025
Summary
A Chlamydia muridarum mutant (intrOv) shows reduced initial infection and epithelial cell invasion, explaining its attenuated genital pathogenicity. This intracellular oral vaccine vector
Area of Science:
- Microbiology
- Vaccinology
- Infectious Diseases
Background:
- Chlamydia muridarum is a pathogen causing genital tract infections.
- An attenuated mutant, intrOv, is explored as an oral vaccine vector.
- The mechanism of intrOv's attenuation is not fully understood.
Purpose of the Study:
- To investigate the mechanism behind the attenuated genital pathogenicity of the Chlamydia muridarum mutant intrOv.
- To evaluate intrOv's infectivity and replication in the mouse genital tract.
Main Methods:
- Intravaginal inoculation of mice with intrOv and a wild-type control strain.
- Quantification of live organisms in vaginal swabs and lower genital tract tissues at different time points.
- Assessment of epithelial cell invasion and intracellular replication.
Main Results:
- IntrOv showed reduced recovery of live organisms in early intravaginal infection compared to the wild-type control.
- A transient deficiency in infecting lower genital tract tissues was observed for intrOv.
- IntrOv exhibited reduced epithelial cell invasion but maintained robust intracellular replication.
Conclusions:
- IntrOv's delayed infection and reduced epithelial cell invasion correlate with its attenuated genital pathogenicity.
- These findings provide a basis for understanding intrOv's attenuation mechanisms.
- Further research is needed to fully elucidate intrOv's attenuation during genital tract infection.
